Christopher Twitty
Chief Scientific Officer at Skye Bioscience, Inc. (SKYE) since April 2025
Christopher Twitty has filed 4 insider reports with the SEC since March 2022, as chief Scientific Officer at Skye Bioscience, Inc. (SKYE) and director at Larkspur Health Acquisition Corp. (ZVSA). The latest filing, on April 2, 2026, reports grant or award and sale back to the company at Skye Bioscience, Inc. (SKYE).
- Filings
- 4
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Christopher Twitty is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officersince April 2025 | 81,242 | $1.065 | Apr 2, 2026 | ||||
| Director | Mar 10, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 31, 2026SKYESEC Form 4 filed by Twitty ChristopherForm 4Grant or awardSale back to the company
- Feb 6, 2026SKYESEC Form 4 filed by Chief Scientific Officer Twitty ChristopherForm 4Grant or award
- Apr 23, 2025SKYENew insider Twitty Christopher claimed ownership of 81,242 sharesForm 3New insider
- Jan 6, 2022ZVSASEC Form 4 filed by Twitty ChristopherForm 4Other acquisition or disposition
Compare Christopher Twitty with
- Christopher Twitty vs Andrew J. Schwab1 shared
- Christopher Twitty vs Punit Dhillon1 shared
- Christopher Twitty vs John P Sharp1 shared
- Christopher Twitty vs Karen L. Smith1 shared
- Christopher Twitty vs Annalisa Jenkins1 shared
- Christopher Twitty vs Tuan Tu Diep1 shared
Other insiders at the same companies
- Andrew J. SchwabSKYE
- 5AM Partners VII, LLCSKYE
- Punit DhillonSKYE
- John P SharpSKYE
- Karen L. SmithSKYE
- Annalisa JenkinsSKYE
- Tuan Tu DiepSKYE
- Deborah H. CharychSKYE
- Paul A. GraysonSKYE
- Kaitlyn ArsenaultSKYE
- Puneet S. AroraSKYE
- Karen A. CashmereZVSA
- James SapirsteinZVSA
- Gregory Gene FreitagZVSA
- Pablo A. GuzmanZVSA
- Stephen C. GloverZVSA
Questions about Christopher Twitty
- What is Christopher Twitty's role at Skye Bioscience, Inc.?
- Christopher Twitty reports to the SEC as chief Scientific Officer at Skye Bioscience, Inc. (SKYE), according to the latest filing on April 2, 2026. Christopher Twitty has also filed as director at Larkspur Health Acquisition Corp. (ZVSA).
- How many shares does Christopher Twitty own?
- After the latest filing that states it, Christopher Twitty directly owned 81,242 shares of Skye Bioscience, Inc. (SKYE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher Twitty bought or sold stock recently?
- No open-market purchases or sales by Christopher Twitty are on file. The filings report grant or award, sale back to the company and other acquisition or disposition.
- How do I get alerts when Christopher Twitty files?
- Follow Christopher Twitty on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher Twitty (SEC CIK 0001870121). Totals count each trade once, skipping amendments whose original is on file, from Mar 10, 2022 on. View on SEC EDGAR